The Watchlist: The Story Behind the Stock

The Watchlist: The Story Behind the Stock

By StockhouseBusinessInvesting
Download on the App Store

The Watchlist: The Story Behind the Stock episodes

  • Bango’s Dual Growth Engines: Payments Stability Meets SaaS Expansion | Bango plc (LSE: BGO) | The Watchlist E11

    Bango PLC (LSE: BGO) is expanding its global reach with new partnerships and a dual growth model built on payments and subscription bundling. In this episode of The Watchlist, CEO Paul Larbey explains how the company balances stability and growth while targeting profitability in 2026.

    Listeners will hear:

    • How Bango’s payments business provides steady profitability.

    • The rapid growth of the Digital Vending Machine SaaS platform.

    • Expansion highlights from the U.S., Japan, Korea, and Africa.

    • The timeline toward sustainable profitability and cash generation.

    This podcast is made in partnership with Bango plc. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    6 min
  • Expanding U.S. Market Access | AJA Health and Wellness (TSXV: AJA) | The Watchlist E10

    AJA Health and Wellness (TSXV: AJA) has secured USD $1.125 million to fund growth and exclusive U.S. marketing rights for its innovative flavonoid-based nasal spray products. In this episode, listeners will hear from CEO Liz Viccars about how this funding supports expansion into e-commerce and B2B markets, including Amazon, while tapping into the fast-growing $124B U.S. complementary and alternative medicine sector.

    Listeners will hear about:

    • The details and purpose of AJA’s $1.125M raise

    • How exclusive U.S. marketing rights open new growth channels

    • The science and innovation behind AJA’s nasal spray line

    • Plans to scale through e-commerce and B2B partnerships

    • The broader market opportunity in alternative medicine

    This podcast is made in partnership with AJA Health and Wellness. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    3 min
  • Terra Innovatum’s Path to First-Mover Nuclear Revenue | Terra Innovatum (NASDAQ: GSRT) | The Watchlist E9

    In this episode of The Watchlist, Terra Innovatum (NASDAQ: GSRT) Chief Business and Development Officer Giordano Morichi discusses the company’s landmark partnership with Ameresco and how it accelerates commercialization of the SOLOW micro modular nuclear reactor. Listeners will hear why this breakthrough positions Terra Innovatum as a first mover toward 2028 commercialization, what differentiates SOLOW from other next-generation nuclear designs, and what the partnership means for investors in GSRT Acquisition Corp.

    This episode covers:

    • The strategic importance of Ameresco’s partnership in accelerating revenue

    • Terra Innovatum’s unique reactor design, safety profile, and scalability

    • Licensing, regulatory, and supply chain milestones leading to 2028

    • Implications for GSRT investors and the broader clean energy transition

    This podcast is made in partnership with Terra Innovatum. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    8 min
  • ZenaTech’s Bold Drone-as-a-Service Expansion | ZenaTech Inc. (NASDAQ: ZENA) | The Watchlist E8

    ZenaTech Inc. (NASDAQ: ZENA | FSE: 49Q | BMV: ZENA) is rapidly scaling its AI-powered drone-as-a-service platform through acquisitions, global expansion, and favorable U.S. policy tailwinds.

    In this episode, listeners will hear:

    • ZenaTech’s strategy to complete 25 acquisitions by mid-2026

    • How the company is diversifying into agriculture, utilities, and inventory management

    • The impact of U.S. regulatory acceleration and executive orders on the drone industry

    • Defense procurement changes that are reshaping drone adoption

    This podcast is made in partnership with ZenaTech Inc. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    7 min
  • $920M NPV Transforms Great Atlantic Project | Atlas Salt (TSXV: SALT) | The Watchlist E7

    In this episode of The Watchlist, Atlas Salt Inc. (TSXV: SALT | OTCQB: REMRF | FSE: 9D00) shares details of its updated feasibility study for the Great Atlantic Salt Project in Newfoundland. Listeners will hear from CEO Nolan Peterson about how this milestone strengthens project economics, enhances financing certainty, and sets the stage for future construction.

    This episode covers:

    • A $920M NPV and improved IRR for the Great Atlantic Salt Project

    • 60% stronger projected cash flows compared to the original study

    • Why enhanced economics reduce project risk and improve financing options

    • The next steps as Atlas Salt prepares for construction

    Learn more: https://atlassalt.com

    This podcast is made in partnership with Atlas Salt Inc. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    4 min
  • BC Gold-Copper: Grid Battery Metals' Next Phase in Prolific Omineca Region | Grid Battery Metals (CELL) | The Watchlist E6

    Grid Battery Metals (TSXV: CELL | OTCQB: EVKRF | FRA: NMK2) updates listeners on its Gold-Copper Property in the prolific Omineca mining region of north-central British Columbia. In this episode, President and CEO Tim Fernback joins Coreena Robertson to discuss the strategic importance of the 275 sq km property, the work completed in the recent exploration program, and why this proven mining district is highly attractive for gold and copper exploration. Listeners will hear the company's perspective on actively building out this key project while maintaining its focus on battery metals.

    This discussion covers:

    • Details on the completed Phase 1 and Phase 2 fall exploration program.

    • The strategic advantage of the Gold-Copper Property's location near Centerra Gold's active Mt Milligan mine.

    • Why the Omineca mining region in BC is a premier jurisdiction for mineral exploration, citing infrastructure, labor, and supportive government policies.

    • CEO Tim Fernback’s insight on why Grid Battery Metals remains a compelling, undervalued opportunity for battery metals investors.

    Company Website: https://gridbatterymetals.com

    Disclaimer: This podcast is made in partnership with Grid Battery Metals and is for information purposes only. It is not an offer to buy or sell securities. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    Hashtags:#GridBatteryMetals #GoldCopper #Omineca #MiningStocks #TSXVCapital #EVKRF #Exploration

    3 min
  • Cash Flow Today, Discovery Tomorrow: ESGold (CSE:ESAU) | The Watchlist E5

    In this episode of The Watchlist, host Ricki Lee is joined by ESGold (CSE:ESAU | OTCQB:ESAUF) CEO Gordon Robb to discuss the company's unique "cash flow first and clean" strategy. Listeners will hear about the fully funded, permitted Montauban gold-silver project in Quebec, which is set to generate near-term revenue from tailings reprocessing starting in 2026.

    Mr. Robb explains how this production-first approach is key to minimizing shareholder dilution and funding deep, systematic exploration, effectively offering investors a dual-track value proposition: production today and discovery potential tomorrow. He also reveals the company's plans to build a scalable platform by replicating the Montauban blueprint with a binding agreement for legacy tailings reprocessing in Colombia.

    The discussion covers:

    • ESGold's core competitive advantage: a "cash flow first and clean" operating model.

    • The status of the Montauban Gold-Silver project: fully funded, permitted, and construction ready for 2026 cash flow.

    • The dual-track strategy: production from tailings to de-risk and fund deep exploration at Montauban.

    • The blueprint for scalability, including the binding agreement to reprocess legacy tailings in Colombia.

    • How the strategy is designed to deliver organic growth, higher margins, and less shareholder dilution.

    Website Link: esgold.com

    Disclaimer: This podcast is made in partnership with ESGold and is for information purposes only. It is not an offer to buy or sell securities. Always do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    4 min
  • A $250M Catalyst De-Risks Path to Production | Highland Copper (TSXV: HI) | The Watchlist E4

    In this episode, Highland Copper (TSXV: HI) CEO Barry O'Shea joins The Watchlist to discuss two major de-risking milestones for the Copperwood project. Listeners will hear about a letter of interest from the US Export-Import Bank for a potential $250 million debt facility and a new plant flowsheet that significantly improves project economics.

    Listeners will hear about:

    • The strategic impact of the $250M letter of interest from the US EXIM Bank.

    • How federal agency support de-risks the overall financing strategy for Copperwood.

    • The updated flowsheet increasing copper recoveries to 87.6% while lowering costs.

    • How Glencore-backed Jameson cell technology provides a performance guarantee.

    • The outlook on upcoming catalysts for the mine and project design.

    Learn more at: https://highlandcopper.com

    This podcast is made in partnership with Highland Copper and is for informational purposes only. It is not an offer to buy or sell securities. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer


    5 min
  • PharmAla Biotech Creates U.S. MDMA Hub, De-Risking Clinical Trials | PharmAla Biotech (CSE:MDMA) | The Watchlist E3

    In this episode of The Watchlist, we're joined by Nicholas Kadyshr, CEO of PharmAla Biotech (CSE:MDMA). He discusses the company's major strategic moves: establishing a U.S. distribution hub for its LaNeo MDMA and launching PharmAla Australia as a dedicated R&D center for its next-generation molecule, ALA-02.

    Listeners will hear Nicholas Kadyshr discuss:

    • The strategic importance of establishing an R&D hub in Australia for the ALA-02 molecule.

    • How a U.S. distribution depot for LaNeo MDMA removes import/export friction for key clinical trial partners.

    • The unique business model of combining drug manufacturing with drug discovery and development in the controlled substance space.

    • How these strategic moves in the U.S. and Australia position the company for long-term leadership.

    For more information, visit: https://www.pharmalabiotech.com/

    This podcast is made in partnership with PharmAla Biotech. The views expressed in this podcast are not investment advice. Investing in securities is speculative and involves a high degree of risk. For our full disclaimer, visit: https://themarketonline.ca/disclaimer

    4 min
  • Accsys (LSE:AXS) CEO on 55% North American Sales Growth & Strategic Expansion | The Watchlist E2

    Accsys (LSE:AXS) has released a new trading update highlighting significant growth and strategic progress. In this episode, we explore the company's 28% year-on-year increase in sales, which was driven by a remarkable 55% surge in Accoya® sales volume in North America, a key market for the firm.

    Host Ricki Lee is joined by Accsys CEO, Dr. Jalena Arsic van Os. Listeners will hear her break down the drivers behind this growth, the medium and long-term outlook for sales between Europe and the US, and how the company plans to maintain its market differentiation and premium pricing power in the current economic climate.

    In this episode, we discuss:

    • The latest trading update, showing 28% year-on-year growth.

    • A 55% surge in North American Accoya® sales volume.

    • The strategic addition of three new distributors to accelerate market penetration.

    • The medium-term sales balance outlook and the long-term shift towards the US market.

    • Accsys's strategy for maintaining its premium pricing power.

    For more information, visit the Accsys website at:https://www.accsysplc.com/

    Disclaimer: The information contained in this podcast is for informational purposes only and does not constitute financial advice. Listeners should conduct their own research and consult with a professional financial advisor before making any investment decisions. The Watchlist does not endorse any specific company or investment. For our full disclaimer, please visit: https://themarketonline.ca/disclaimer

    4 min

About The Watchlist: The Story Behind the Stock

From the publisher's feed

Get the story behind the stock. The Watchlist delivers exclusive, same-day interviews with CEOs from market-moving companies around the world, moments after their news hits the wire. Cut through the…